Biodegra - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 3,204,527 | 2,081,935 | 3,676,829 | 1,995,615 | 1,276,148 | 1,307,119 | 1,086,610 | 865,008 |
| Profit before tax | 174,809 | 16,846 | 82,824 | 3,601 | 8,638 | 16,311 | 10,872 | 13,446 |
| Net profit | 148,382 | 14,349 | 70,361 | 2,405 | 4,503 | 13,338 | 7,018 | 8,259 |
| Equity | 1,190,847 | 1,205,196 | 1,275,557 | 1,277,962 | 1,282,465 | 1,295,803 | 1,302,821 | 1,311,080 |
| Liabilities | 814,832 | 560,124 | 649,880 | 218,382 | 146,348 | 578,119 | 499,332 | 83,543 |
| Non-current assets | 521,992 | 425,839 | 369,638 | 671,656 | 612,706 | 1,331,700 | 1,160,651 | 1,052,903 |
| Current assets | 1,483,687 | 1,339,481 | 1,553,799 | 814,688 | 816,107 | 539,556 | 637,948 | 338,173 |
| Total assets | 2,005,679 | 1,765,320 | 1,923,437 | 1,486,344 | 1,428,813 | 1,871,256 | 1,798,599 | 1,391,076 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 157,102 | 154,398 | 116,370 |
| Social insurance contributions | - | - | - | - | - | 33,108 | 35,238 | 36,283 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -13.2% | -35.0% | +76.6% | -45.7% | -36.1% | +2.4% | -16.9% | -20.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 7.4% | 0.8% | 3.7% | 0.2% | 0.3% | 0.7% | 0.4% | 0.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 12.5% | 1.2% | 5.5% | 0.2% | 0.4% | 1.0% | 0.5% | 0.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.6% | 0.7% | 1.9% | 0.1% | 0.4% | 1.0% | 0.6% | 1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.5% | 0.8% | 2.3% | 0.2% | 0.7% | 1.2% | 1.0% | 1.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.7 | 0.5 | 0.5 | 0.2 | 0.1 | 0.4 | 0.4 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 78,318 | 81,645 | 165,251 | 114,035 | 102,092 | 110,461 | 111,447 | 98,858 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biodegra - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-04-23 | 2024-05-14 | 0.07 |
| 2024-01-16 | 2024-02-08 | 8.96 |
| 2022-04-28 | 2022-05-08 | 0.05 |
| 2022-03-16 | 2022-04-10 | 6.17 |
Biodegra - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-11-19 | 2024-11-23 | 29.0 |
| 2024-11-18 | 2024-11-18 | 50289.5 |
| 2024-11-17 | 2024-11-17 | 50288.89 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biodegra, UAB (code 123919953) is a Private Limited Liability Company engaged in materials recovery. In 2025, the company generated revenue of €865.0K and net profit of €8.3K, with a net profit margin of 0.9%. Revenue declined by 20.4% year on year and by 33.8% compared with 2023, indicating a softer top-line trend over the latest three years. Profitability remained positive throughout the period, although earnings were modest relative to turnover. Net profit fell from €13.3K in 2023 to €7.0K in 2024, then improved slightly in 2025.
The balance sheet remained very conservatively financed. At the end of 2025, total assets stood at €1.39M, equity at €1.31M and liabilities at €83.5K. The equity ratio was 94.2% and the debt-to-equity ratio was 0.06, showing limited leverage. Asset turnover was 0.62x, while return on equity and return on assets were both 0.6%. Revenue per employee was €108.1K and profit per employee was €1.0K, suggesting moderate operating productivity.
The balance sheet remained very conservatively financed. At the end of 2025, total assets stood at €1.39M, equity at €1.31M and liabilities at €83.5K. The equity ratio was 94.2% and the debt-to-equity ratio was 0.06, showing limited leverage. Asset turnover was 0.62x, while return on equity and return on assets were both 0.6%. Revenue per employee was €108.1K and profit per employee was €1.0K, suggesting moderate operating productivity.